Warning: json_decode() expects parameter 1 to be string, array given in /nfs/c05/h01/mnt/160396/domains/ngoc.com/html/wp-content/plugins/tablepress/controllers/controller-frontend.php on line 395
Warning: in_array() expects parameter 2 to be array, null given in /nfs/c05/h01/mnt/160396/domains/ngoc.com/html/wp-content/plugins/tablepress/controllers/controller-frontend.php on line 396
Bradley J.G. Larson, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) upon completion of his Fellowship at the University of Florida in 2004.
Dr. Larson is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia.
|Personal Data||Birthplace: Minneapolis, MN|
|Undergraduate Education||BS with distinction, Zoology, 1993
University of Wisconsin-Madison
|Medical Education||Doctor of Medicine
University of Wisconsin-Madison Medical School
1993 – 1997
|Postdoctoral Training||INTERNSHIP AND RESIDENCY
University of Florida, Gainesville, FL
1997 – 2000
Chief Resident, Internal Medicine, University of Florida
|Board Certification||American Board of Internal Medicine, Medical Oncology, 2004|
|Medical Licensure||State of Georgia, 2004|
|Professional Societies||Medical Association of Georgia
Georgia Society of Clinical Oncology
|Honors||Election to College of Letters and Sciences Dean’s List, 1989, 1991
Peter and Emily Lound Scholarship, 1993
Recipient of Letter of Commendation for Academic Achievement, 1993, 1996
UW Medical Student Association Leadership Award, 1994, 1995
Student Leadership Award, 1995
“Resident of the Month” Department of Emergency Medicine, 1999
Senior Resident Teaching Award, 1999
Larson B, Waples J, Lynch J. A phase II study of patients with relapsed or refractory indolent non-Hodgkin’s lymphoma treated with Gemcitabine. Accepted by Clinical Lymphoma. Publication Pending.
Smock AL, Larson B, Brown C, Conti CR. Echocardiographic assessment of left ventricular function early after Q-wave Myocardial Infarction predicts thirty day prognosis. Clinical Cardiology 24(3): 191-195, 2001.
“CD 23 status predicts survival in atypical CLL”. ASH supplement, Astract 2000.
|Major Research Interests||Clinical Trials (Oncology & Hematology)|